
Tegoprazan Shows Superior Efficacy and Safety in Treating Esophageal Conditions in Phase 3 trial
In a phase 3 trial Tegoprazan Shows Superior Efficacy and Safety in Treating Esophageal Conditions. It was found that Tegoprazan acted faster and was more effective than lansoprazole (a PPI), achieving all primary and secondary endpoints during the healing …